Molecular glioblastomas - better prognosis after correcting for treatment differences
Authors
Robinson, S. D.Clark, M.
MacColl, J.
Forner, S.
Wong, A.
Tirumala, L.
Hatton, N. L.
Lathangue, H.
Wontumi, S.
Conkey, D.
Rayner, L.
Patel, Karan
de Boisanger, J.
Fullagar, A.
Lachmann, E.
Durage, P. T. T.
Edlmann, E.
Pillai
de Luna, P. J.
Teoh, M.
Choudhury, M.
Williams, A.
Norris, T.
Golten, J.
Murphy, S.
Kingdon, S.
Yogalingham, K.
Stewart, G.
Lau, S. E.
Kahan, J.
Olukiran, G.
Heckelmann, M.
Giamas, G.
Critchley, G.
Chandy, E.
Affiliation
The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2024
Metadata
Show full item recordCitation
Robinson SD, Clark M, MacColl J, Forner S, Wong A, Tirumala L, et al. MOLECULAR GLIOBLASTOMAS - BETTER PROGNOSIS AFTER CORRECTING FOR TREATMENT DIFFERENCES. Neuro-oncology. 2024 OCT 17;26:V29-V30. PubMed PMID: WOS:001340502000087. English.Journal
Neuro-OncologyDOI
10.1093/neuonc/noae144.087Additional Links
https://dx.doi.org/10.1093/neuonc/noae144.087Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noae144.087